ADRB2 and aggressive systemic mastocytosis: To test whether asthmatic ASM is characterized by β2AR dysfunction, non-asthmatic and asthmatic HASMCs were challenged with albuterol (β-agonist) acutely (0, 5, 10 and 20 minutes) and cAMP generation assessed as a measure of βAR function.